
FOR INDUSTRY: biotech, pharma and medtech
The whole research pipeline, in one room.
We put industry in the room with the researchers, health services and policymakers who decide whether Australian discoveries become Australian treatments and technologies. Pharma, biotech, medtech and digital health companies join to work side by side with the universities, medical research institutes, health services and health charities whose research drives the products and services Australians rely on.

What we do for you

Health innovation
Turning discovery into treatment, technology and manufacturing here at home. We make the case for the R&D incentives, clinical trial settings and procurement pathways that decide whether that happens.

The people who decide
Our submissions, roundtables and the Parliamentary Friends of Health and Medical Research put research leaders and policymakers in the same conversation. You’re in it.

Early sight of what’s coming
Research priorities, workforce pressures and funding shifts, seen from every part of the pipeline before they reach you.

We contributed to the establishment of the $700 million MRFF Frontier Health and Medical Research Initiative, created in the 2018 Budget.
What we’ve published that you can use
Submission · 2026
Response to Capital Gains Tax Reforms: Arrangements for Innovative Start-Ups Consultation Paper
SUbmission· 2026
Response to the Consultation on Streamlining and Simplifying IP Regulation
Submission · 2024
Embedding Research into the Allied Health Workforce Strategy
Already a member?
Bring your translation priorities to our Health Innovation work, sponsor a session, or put your people in front of the sector at our Awards night.
Not a member yet?
We don’t represent industry. That’s exactly why industry’s case carries further when it’s made alongside the rest of the system. Fees are set by sector and size.
Want to give?
Looking for research partners? See who’s at our table: